USA - NYSE:ELV - US0367521038 - Common Stock
Taking everything into account, ELV scores 4 out of 10 in our fundamental rating. ELV was compared to 101 industry peers in the Health Care Providers & Services industry. While ELV is still in line with the averages on profitability rating, there are concerns on its financial health. ELV has a correct valuation and a medium growth rate. Finally ELV also has an excellent dividend rating.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 4.4% | ||
ROE | 12.26% | ||
ROIC | 5.9% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 4.6% | ||
PM (TTM) | 2.83% | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.65 | ||
Debt/FCF | 5.7 | ||
Altman-Z | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | N/A | ||
Quick Ratio | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 10.07 | ||
Fwd PE | 10.55 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 14.16 | ||
EV/EBITDA | 9.24 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 2.16% |
332.66
+9.54 (+2.95%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 2.16% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 10.07 | ||
Fwd PE | 10.55 | ||
P/S | 0.4 | ||
P/FCF | 14.16 | ||
P/OCF | 11.69 | ||
P/B | 1.71 | ||
P/tB | 19.39 | ||
EV/EBITDA | 9.24 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 4.4% | ||
ROE | 12.26% | ||
ROCE | 7.72% | ||
ROIC | 5.9% | ||
ROICexc | 6.38% | ||
ROICexgc | 11.77% | ||
OM | 4.6% | ||
PM (TTM) | 2.83% | ||
GM | N/A | ||
FCFM | 2.8% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.65 | ||
Debt/FCF | 5.7 | ||
Debt/EBITDA | 2.8 | ||
Cap/Depr | 75.47% | ||
Cap/Sales | 0.59% | ||
Interest Coverage | 250 | ||
Cash Conversion | 62.96% | ||
Profit Quality | 98.73% | ||
Current Ratio | N/A | ||
Quick Ratio | N/A | ||
Altman-Z | N/A |